PFAS Exposure Linked to Gut Microbiome Changes and Kidney Function Decline

A new study from the University of Southern California links PFAS "forever chemical" exposure in young adults to reduced gut health, potentially driving kidney disease later in life. The research suggests that changes in gut bacteria and associated metabolites caused by PFAS may be responsible for up to 50% of the decrease in kidney function observed over a four-year period. This builds on previous findings connecting PFAS to gut health effects and the growing understanding of the relationship between gut health and kidney function.

The study focused on a small cohort of young adults, primarily Hispanic, a group with high rates of metabolic diseases and kidney disease risk. Researchers collected blood and stool samples to measure PFAS levels, gut microbiome bacteria, and circulating metabolites, then assessed kidney function four years later. They found reductions in anti-inflammatory metabolites and the bacteria that produce them, along with increases in inflammatory metabolites, which can lead to reduced kidney function and increased risk of dialysis or kidney transplant, especially in individuals with diabetes or other kidney-affecting diseases.

While the study's sample size was small, the findings suggest potential avenues for treatment or prevention of PFAS-induced kidney disease. The researchers emphasize the need for wider exploration of this issue and underscore the importance of reducing PFAS production and environmental release. They also suggest that dietary interventions to balance gut bacteria could be beneficial in managing PFAS exposure effects.

This research underscores the urgent need for innovative PFAS removal technologies  for water treatment and environmental remediation.

For further reading, please click here.